We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » PhRMA Defends Drug Patent Provisions in CAFTA
PhRMA Defends Drug Patent Provisions in CAFTA
June 14, 2005
Nothing in the Central American Free Trade Agreement (CAFTA) undermines global trade rules that allow developing countries to access pharmaceuticals, PhRMA said in a statement that counters critics who argue the trade deal favors large drugmakers at the expense of poor nations’ health needs.